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“Denture Stomatitis – A Clinical Update” 
 
Abstract: Denture stomatitis is a benign condition, usually asymptomatic, that can affect 
edentulous patients. Studies have reported a prevalence of denture stomatitis affecting over 
75% of denture wearers, and whilst the aetiology may be multifactorial, Candida albicans 
has a strong association with the condition, along with denture trauma and poor denture 
hygiene being associated local risk factors. This paper describes the aetiology, diagnosis and 
treatment of denture stomatitis, with the aim of helping clinicians to provide appropriate 
management of this condition. 
 
 
 
Clinical Relevance: Denture stomatitis can be a recurrent problem amongst denture wearers 
and is often asymptomatic to the patient. Dental practitioners should be able to identify and 
manage this condition. 
 
 
Objective Statement: The reader should understand the clinical implications of denture 
stomatitis and its management. 
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Introduction: 
Denture stomatitis (DS) is a benign and common disorder that affects denture wearers. It 
may be described as a chronic inflammation, with erythema of the oral mucosal tissues 
supporting a removable prosthesis,1 and is not caused by an allergy to the denture’s 
constituents. DS has also been known by other names including “chronic denture palatitis”, 
“chronic atrophic candidiasis”, “denture sore mouth” and “denture induced candidiasis”. 
The condition is usually asymptomatic, but can give rise to bleeding of the affected areas of 
mucosa, a burning sensation, halitosis, a bad taste and xerostomia.2,3 The prevalence of DS 
ranges from 15% to 77.5%1,4,5 and whilst a higher incidence has been reported in the elderly 
and females1,5,6 this is not always the case.7 This marked difference in prevalence can be 
attributed to different populations of patients studied. Various studies have found that 
those patients that are institutionalised are especially susceptible to DS, possibly as a result 
of their impaired immune system, overall general health, xerostomia, decreased motor 
function leading to an inability to carry out good oral hygiene, and the reliance on others to 
carry out oral hygiene measures.8,9,10  
Presentation: 
DS can affect both partial and complete denture wearers2 although is commonly seen on the 
palatal mucosa beneath a maxillary complete denture.1,5,11 DS rarely affects the lower arch, 
possibly as a result of the washing effect of saliva and the cleansing action of the tongue, 
whereas the upper arch the prosthesis may have a better peripheral seal and thus contain its 
own micro-environment.12 
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The most widely used classification for DS is that of Newton11 who classified the condition 
according to the clinical appearance of the inflamed mucosa underneath the denture:  
Type I (Figure 1): Localised areas of inflammation, possibly caused by trauma 
Type II (Figure 2): Generalised erythema covering the denture bearing area. This is the most 
common presentation9 
Type III (Figure 3): Inflammatory papillary hyperplasia, usually affecting the hard palate or 
alveolar ridges 
The condition was later re-classified by Budtz-Jorgensen and Bertram13 according to the type 
of inflammation observed on the mucous membrane (Table 1).  
Aetiology: 
The aetiology of DS appears to be multifactorial.1,5,12 Candida albicans has been shown to be 
highly implicated in the aetiology of DS,1,8,12,14 and may account for 90% of cases of denture 
stomatitis.15 However, a number of bacteria such as Staphylococcus, Streptococcus, 
Fusobacterium, and Bacteroides species9 can also be involved. Candida’s change in role from 
commensal to parasite occurs when there is a change in the immune balance between host 
and fungus. It is the host’s weaker defence mechanisms and the presence of ideal growth 
condition for the Candida that allows the tissue irritation.8,9 Acrylic resin has been shown to 
be suitable for fungi to colonize, providing suitable conditions for adherence and 
proliferation, and this is also the case with the use of resilient soft linings as they have a 
relatively high surface porous texture. 
Risk factors: Not all denture wearers suffer from DS, and a number of local and systemic 
factors have been shown to predispose an individual to the condition (Table 2). Long-term 
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soft tissue trauma from poorly fitting or unstable dentures, patients with parafunctional 
habits, or those with surface roughness has been associated with Newton Type I lesions,5,13 
the inflammatory changes arising as a result of increased occlusal loading16 and an increase 
in Candida receptor molecules within the tissues. Patients who wear implant-supported 
prostheses that have a greater distribution of occlusal loads compared to conventional 
prostheses have been shown to have significantly decreased numbers of DS episodes. 
In addition, the relatively rough fitting surface of the denture facilitates the retention of 
micro-organisms, and may act as a reservoir. Surface irregularities can also shield micro-
organisms from physical oral hygiene measures.  
Poor denture hygiene allows the increased growth of pathogenic micro-organisms within the 
dental plaque on the fitting surfaces of dentures, and there is a strong association between 
lack of denture hygiene and Newton Type II and III lesions.1,5,12 Continuous wearing of a 
denture, especially at night, allows Candida to colonise the biofilm on the mucosa under the 
denture.17 A relatively anaerobic environment is created with a decreased pH, which favours 
the growth of Candida. In addition, saliva is prevented from being able to cleanse the 
denture bearing area and allows proliferation of pathogenic species.13 Dentists may also not 
be very attentive towards the quality of denture hygiene in their patients.18 
Smoking is a systemic risk factor for DS, and smokers have been shown to have increased 
rates of Candida coverage19 and increased chances of being an oral Candida carrier. The 
exact reason why smokers are predisposed to DS is unclear, but it is thought that aromatic 
hydrocarbons in smoke cause localised epithelial alterations. 
Denture wearers with a high sugar intake in their diet are also at greater risk of DS as a result 
of glucose being able to stimulate the growth of Candida species and increasing the 
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adhesion of fungi within the dental plaque. Sugar consumption may be just as significant as 
poor denture hygiene in development of DS.8 
Other systemic factors have been shown to predispose denture wearers to DS, and these 
include: nutritional deficiencies (iron, folate, Vitamin B12),5,21 immune deficiencies (HIV),5,20,21 
use of broad spectrum antibiotics,5,15,21 corticosteroid therapy,5,20,21 xerostomia21 and 
radiotherapy to the head and neck area.21 
Diagnosis: 
Diagnosis can be based upon the clinical appearance of a well-demarcated area of erythema 
corresponding to the fitting surface of the denture. Tissue biopsy is not usually warranted 
unless there are other suspicious features of the condition. If a biopsy were to be taken, 
histology will show evidence of proliferative or degenerative responses, along with reduced 
keratinisation and epithelial atrophy. A gram-stained smear of the palate can demonstrate 
the presence of Candidal hyphae, and swabs can also be taken of the fitting surface of the 
denture. 
Management: 
It is important to treat all patients with DS, even if the condition is mild and asymptomatic, 
to prevent it progressing to the Type III form when a surgical option (scalpel, cryosurgery, 
laser surgery or electro-surgery) is likely to be needed for management. In addition, patients 
suffering from DS may also develop angular cheilitis, classically presenting as bilateral 
erythematous fissuring at the corners of the mouth. The treatment of DS should target the 
aetiological and risk factors discussed earlier, and a number of treatment modalities may be 
needed (Table 3): 
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Management of underlying systemic disease: is needed not just for the patient’s overall 
general health, but also to ensure that any underlying systemic risk factors for DS are 
investigated and reduced, where possible, and liaison with the patient’s GMP may be 
needed. All smokers should be offered smoking cessation advice, and some patients may 
benefit from dietary advice (especially in relation to carbohydrate intake), and some may 
benefit from the prescription of saliva substitutes for treatment of xerostomia. 
Improving the fit of poorly fitting or unstable dentures:  is needed in order to eliminate soft 
tissue trauma from the denture. Treatment may involve smoothing rough areas of the fitting 
surface of the denture, relining the denture, or remaking the denture.  
If a new denture is prescribed, the elimination of tissue inflammation should be achieved 
before new impressions are taken. Tissue conditioners, such as Visco-gel (DENTSPLY) 
(Figures 4a and 4b) can be used to temporarily improve the fit and stability of existing 
dentures, as well as reduce inflammation of the mucosa (Figure 5). Anti-fungal agents have 
previously been incorporated into soft lining materials, but with limited success. Tissue 
conditioners should be used with caution as they have been shown to promote growth of 
Candida and can also be difficult for patients to keep clean, resulting in the persistence of 
inflammation. Continuous cleaning of these conditioning materials can also alter their 
structure and properties through water absorption, leading to hardening and distortion.22 
The use of a sponge to aid cleaning of soft linings has been suggested, but this can result in 
less thorough cleaning. If tissue conditioners are used, regular review of the patient should 
be carried out in order to check that the tissue conditioner is still viable as their rapid 
deterioration can cause further mucosal trauma. Repeated replacement may be needed.  
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Improvement in denture hygiene: is needed to reduce the micro-organism populations on 
the fitting surface of the dentures and is an essential part of management. Various methods 
of denture hygiene have been advocated, and active methods appear to be more successful 
than passive methods.23 Effective active methods for cleaning dentures are thorough 
brushing of the denture in combination with the use of a non-abrasive proprietary paste or 
warm soapy water, and this should be carried out after every meal. Resolution of DS has 
shown to be hastened if the patient can remove the dentures for an extended period of time 
(up to six weeks),17 although patients may not be willing to do this. However, it is essential 
that patients remove their dentures at night. It is now deemed acceptable to leave dentures 
to dry out overnight as firstly, organisms that inhabit the biofilm do not survive prolonged 
drying out, and secondly, there is no evidence that leaving dentures to dry out overnight will 
cause the acrylic to warp.24 Improved denture hygiene is key to treating all types of DS and 
patients must understand the importance of their own denture hygiene regime. The use of a 
sonic bath filled with suitable cleaning solution can also be beneficial, and these are 
relatively inexpensive for the patient to purchase. 
Passive methods of denture cleaning include soaking the dentures in antimicrobial 
mouthrinses and microwave disinfection. Chlorhexidine mouthwash is widely available and 
exhibits good antibacterial and antifungal properties. Acrylic dentures that are soaked in 2% 
Chlorhexidine solution have inhibited Candida growth, and a 2% Chlorhexidine solution has 
also been found to prevent the adherence of Candida for a longer period of time when 
compared to other antifungal solutions such as Amphotericin B and Nystatin. However, as 
soon as treatment was stopped, DS recurred.25 This, along with the fact that as 
Chlorhexidine gluconate mouthrinse is only available as a 0.2% solution in the UK, the use of 
Chlorhexidine should only be considered for controlling plaque, but not for inhibiting the 
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growth of Candida. In addition, 0.2% Chlorhexidine solution is not normally recommended to 
be used daily as a denture cleaner, as this may lead to staining of the denture and altered 
taste.  
Sodium hypochlorite solution can be used to soak dentures, and this can lead to a significant 
reduction of both Candida and plaque. Patients suffering from DS should soak acrylic 
dentures twice daily for 15 minutes in a 0.02% (50 parts water in 1 part Miltons) solution. 
This method of disinfection should be used for short periods of time only as the hypochlorite 
will eventually bleach the acrylic resin and corrode any metal components.26 
The use of a ‘denture box’27 has been suggested to aid disinfection of dentures, especially 
for those wearers with dexterity problems. 
In addition to methods of thorough cleaning of the denture itself, the use of a toothbrush to 
clean the palate after every meal and at night for a period of three months can reduce 
palatal inflammation, and patients who carry out this regime are nearly four times as likely 
to stay in remission of DS. This may be as a result of the palatal biofilm being removed, 
leading to increased keratinisation, a reduction in the infiltration of inflammatory cells, and 
an increased proliferation of fibroblasts and collagen synthesis. The overall result being the 
formation of a mechanical barrier to microbial colonisation.28 
Microwave disinfection of dentures is a relatively cheap and safe method for cleaning 
dentures, and full sterilisation of complete dentures has been achieved using a setting of 
650W for 3 minutes. This process has been shown to be as effective as the use of topical 
anti-fungal agents for treating DS, and is favoured over anti-fungal treatments as it is unlikely 
to lead to resistant strains of Candida developing. However, this method of denture cleaning 
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should be used with caution as the heat generated can alter the dimensional stability of the 
dentures. 
Use of topical and systemic antifungal agents: can be used to treat cases of DS that fail to 
respond to local, conservative measures. Antifungal agents should not be used as a sole 
treatment modality as whilst antifungal medication can significantly reduce palatal 
inflammation, if  they are prescribed in isolation without assessment of underlying causes, 
relapse occurs within 2-4 weeks of stopping treatment.29,30 However, the benefits of using an 
antifungal medication are enhanced if used in conjunction with improved denture hygiene.29 
If antifungal medication is used, one of the following drugs are recommended26 to be 
prescribed for a treatment period of 7 days: 
 Miconazole 24mg/ml gel – Applied to the fitting surface of the denture four times daily 
 Fluconazole 50mg capsules – One to be taken daily 
 Nystatin 100,000 units/ml oral suspension – 1ml oral rinse four times daily after food for 
five minutes, and then swallowed 
The topical application of Miconazole gel has the advantage in that the drug is held in close 
contact with the affected mucosa for a long period of time, and is available in a sugar-free 
presentation. Miconazole gel can be beneficial for patients with poor compliance for 
removing their dentures at night, and can also be used for the treatment of angular cheilitis 
as it is effective against Staphylococcus aureus. Its use should be continued for 48 hours 
after the lesions have healed. Care should be taken for patients undergoing anticoagulant 
therapy as Miconazole has been shown to enhance the effect of Warfarin. The use of 
systemic Fluconazole may have the added benefit of eliminating yeasts that are present in 
the gastrointestinal tract, but should not be prescribed for patients taking Warfarin or 
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statins, and Fluconazole should not be prescribed for a period of longer than 14 days 
duration. Nystatin oral suspension can be prescribed where the use of Miconazole or 
Fluconazole is contra-indicated. If Nystatin oral suspension is used, patients must be 
instructed to remove their dentures whilst rinsing, else the drug is unlikely to come into 
contact with the inflamed mucosa. 
Recent developments: further proposed ideas to prevent the recurrence of DS include:  the 
use of polymerised coatings on the denture surface to reduce the adherence of Candida 
albicans, incorporating Candida-specific antibodies within the denture material, and the use 
of antifungal agents within the denture material. 
Conclusion: 
DS is a condition that commonly affects denture wearers, and should be treated even if 
asymptomatic. The condition requires a combined treatment approach from both patient 
and clinician, and the role of the patient must be stressed. Management of aetiological risk 
factors is key in order to prevent recurrence. Treatment modalities may include: treatment 
of any underlying systemic risk factors, improvement in the fit of existing dentures, 
replacement of existing dentures, improved denture hygiene and the use of antifungal 
agents. Whichever methods are employed, the main aim of treatment is to eradicate the 
biofilm from the patient’s dentures. Regular review of patients suffering from DS is essential 
in order to ensure long-term successful treatment of the condition. 
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Figure 1. Newton’s Type I denture stomatitis showing areas of localised inflammation 
 
 
 
Figure 2. Newton’s Type II denture stomatitis showing generalised erythema covering the 
denture bearing area 
 
 
 
Figure 3. Newton’s Type III denture stomatitis showing inflammatory papillary hyperplasia 
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Figures 4a and 4b. Viscogel (Dentsply) is a suitable tissue conditioner 
          
 
 
Figure 5.  A complete upper denture relined with Viscogel (Dentsply) tissue conditioner 
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Table 1: The classifications of Denture Stomatitis 
 
Newton - 1962 
(Clinical Appearance) 
Budtz-Jorgensen and Bertram - 1970 
(Inflammation Observed) 
Type I  Localised inflammation  Simple diffuse inflammation 
Type II Generalised erythema covering the 
denture bearing area 
Simple localised inflammation 
Type III Inflammatory papillary hyperplasia Granular inflammation 
 
 
Table 2: Local and systemic risk factors for Denture Stomatitis 
 
Local Risk Factors Systemic Risk Factors 
Denture trauma  Smoking 
Poor denture hygiene Diabetes 
Nocturnal denture wear Nutritional deficiencies 
 Immune deficiencies 
 Broad spectrum antibiotics 
 Corticosteroid therapy 
 High carbohydrate diet 
 Xerostomia 
 Radiotherapy 
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Table 3: Treatment options for Denture Stomatitis 
Treatment Options  
Management of underlying systemic disease  Smoking cessation advice 
 Dietary advice 
 Liaison with GMP 
 Salivary substitutes 
Improve fit of poorly-fitting dentures  Smooth rough areas of denture 
 Use of tissue conditioners 
 Provision of new denture 
Improve denture hygiene  Improved brushing of denture 
 Leaving denture out at night 
 Use of sonic bath 
 Soak dentures in hypochlorite 
 Microwave disinfection 
Use of topical and systemic antifungals  Miconazole oral gel 
 Fluconazole capsules 
 Nystatin oral suspension 
 
